Molecular Research on Hypertensive and Metabolic Disorders in Pregnancy
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Reproduction".
Deadline for manuscript submissions: closed (29 February 2024) | Viewed by 2865
Special Issue Editors
Interests: vascular and metabolic adaptations in pregnancy
Special Issues, Collections and Topics in MDPI journals
Interests: pregnancy and gestational diabetes
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Despite many leaps forward, there is a continuous struggle with tragic, and often preventable, deaths related to poor maternal health. Poor maternal health and birth outcomes occur worldwide. Improving the health of mothers and babies is an important public health priority. Cardiovascular disease constitutes nearly 30% of pregnancy-related deaths. Preeclampsia is a hypertensive pregnancy diagnosed before 20 weeks gestation that results in significant vascular and metabolic dysfunction in the mother and offspring, and neonatal morbidity and mortality. Preeclampsia is most common in women with gestational diabetes, a pregnancy complication caused by an inability to use sugar properly during pregnancy, and this may result in giving birth to a large baby. Gestational diabetes and preeclampsia are both conditions that only occur during pregnancy. Gestational diabetes with preeclampsia is a condition that may also be called toxemia of pregnancy or pregnancy-induced hypertension; this occurs in about 10 to 30 percent of women with gestational diabetes. The development of strategies for reducing the risk factors and complications, both acute and long-term, is crucial in decreasing the impact of the condition. Researchers and practitioners in the field are constantly searching for advancements in the prevention, care, and diagnosis of pregnancy disorders.
A Special Issue of Biomolecules has been organized to present a collection of innovative and high-quality research studies focused on “Molecular Research on Hypertensive and Metabolic Disorders in Pregnancy”. We cordially invite authors to submit qualitative and quantitative studies and reviews addressing original research and case studies that fill gaps in the knowledge, or that provide an in-depth analysis of the present knowledge.
Dr. Madhulata Singh Chauhan
Dr. Yuanlin Dong
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pregnancy
- high risk pregnancy
- feto-placental growth
- chronic and gestational hypertension
- preeclampsia, gestational diabetes
- spontaneous abortion
- preterm birth
